More about

Headache

News
November 20, 2023
2 min read
Save

Ubrogepant efficacious, well tolerated for treating migraine in prodromal phase

Ubrogepant efficacious, well tolerated for treating migraine in prodromal phase

Treatment with 100 mg ubrogepant was effective at curbing migraine attacks when administered during the prodromal phase compared with placebo, according to research from The Lancet.

News
October 02, 2023
2 min read
Save

What is hypertension?

What is hypertension?

Hypertension is also known as high blood pressure. It is defined as transitory (short-lived) or chronic elevation of the blood pressure in the arteries. This elevation may lead to cardiovascular damage. When left untreated, the damage to the circulatory system can cause heart attack, stroke, heart failure, heart disease and kidney failure.

News
July 14, 2023
1 min read
Save

Blood pressure-lowering meds more effective than placebo at reducing migraine frequency

Blood pressure-lowering meds more effective than placebo at reducing migraine frequency

A systematic literature review determined that various classes of blood pressure-lowering medication reduced frequency of migraine days per month compared with placebo, according to a study published in Cephalalgia.

News
June 30, 2023
1 min read
Save

IV ketamine reduced pain by 50% in pediatric patients with refractory headache

IV ketamine reduced pain by 50% in pediatric patients with refractory headache

AUSTIN, Texas — Treatment with IV ketamine for pediatric refractory headache resulted in a 50% reduction in pain at discharge, with nearly two-thirds of patients not requiring rescue care within 1 month, according to a poster presentation.

News
June 27, 2023
1 min read
Save

Highlights from the American Headache Society Annual Meeting for PCPs

Highlights from the American Headache Society Annual Meeting for PCPs

Last week, Healio provided live coverage of the American Headache Society Annual Meeting in Austin, Texas, where health care professionals gathered for the latest updates on headache disorders.

News
June 26, 2023
2 min read
Save

Sustained migraine relief reported with long-term eptinezumab

Sustained migraine relief reported with long-term eptinezumab

AUSTIN, Texas — Long-term use of eptinezumab resulted in improvements in symptoms and headache days in patients with chronic migraine and medication-overuse headache, according to a poster presented here.

News
June 23, 2023
2 min read
Save

Dihydroergotamine nasal powder provides sustained pain relief in migraine patients

Dihydroergotamine nasal powder provides sustained pain relief in migraine patients

AUSTIN, Texas — Sustained freedom from pain and the most bothersome migraine symptom was achieved in more patients treated with investigational STS 101 compared with placebo, according to a study presented here.

News
June 17, 2023
1 min read
Save

Racial, economic disparities in pediatric headache care highlight importance of follow-up

Racial, economic disparities in pediatric headache care highlight importance of follow-up

AUSTIN, Texas — Significant improvement was reported in children who have follow-up visits to a headache clinic, although Black patients and patients on Medicaid were less likely to complete these visits, according to data presented here.

News
June 16, 2023
1 min read
Save

Hispanic patients satisfied with telemedicine for headache care

Hispanic patients satisfied with telemedicine for headache care

AUSTIN, Texas — Hispanic patients with headache disorders were overall satisfied with telemedicine services, regardless of English language proficiency, according to a poster presented here.

News
June 02, 2023
1 min read
Save

Reflection on a patient encounter: How previous diagnoses can impact bias

Reflection on a patient encounter: How previous diagnoses can impact bias

I want to reflect on a recent patient I admitted: a woman in her 40s who presented with an intractable headache.

View more